2023
DOI: 10.1016/j.arbres.2023.02.010
|View full text |Cite
|
Sign up to set email alerts
|

Predictors of Stability/Improvement of Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis After One Year of Treatment With Nintedanib

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

2
0

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 9 publications
0
1
0
Order By: Relevance
“…To find a cure for this debilitating and fatal disease, it is imperative to deepen our understanding of the pathogenetic mechanisms underlying IPF, including altered cell-cell crosstalk and secretion of pathogenic molecules in the fibrotic milieu. Ongoing research continues to explore novel therapeutic options, personalized strategies and therapeutic combinations as well as possible biomarkers of diagnosis and/or predictors of treatment efficacy [ 11 ]. In this review, we provide a comprehensive summary of the current pharmacological treatments of IPF, clinical trials and future directions.…”
Section: Introductionmentioning
confidence: 99%
“…To find a cure for this debilitating and fatal disease, it is imperative to deepen our understanding of the pathogenetic mechanisms underlying IPF, including altered cell-cell crosstalk and secretion of pathogenic molecules in the fibrotic milieu. Ongoing research continues to explore novel therapeutic options, personalized strategies and therapeutic combinations as well as possible biomarkers of diagnosis and/or predictors of treatment efficacy [ 11 ]. In this review, we provide a comprehensive summary of the current pharmacological treatments of IPF, clinical trials and future directions.…”
Section: Introductionmentioning
confidence: 99%
“…No scientific data are available on the slow course of disease in the elderly. Furthermore, no demographic, clinical, and functional variables may predict the stabilization/progression of disease, even in patients exposed to antifibrotic therapy [5].…”
mentioning
confidence: 99%